168 related articles for article (PubMed ID: 11420859)
1. [The revival of an old diagnostic marker: C-reactive protein].
Sela B
Harefuah; 2001 Jun; 140(6):541-6. PubMed ID: 11420859
[No Abstract] [Full Text] [Related]
2. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.
Smith SC; Anderson JL; Cannon RO; Fadl YY; Koenig W; Libby P; Lipshultz SE; Mensah GA; Ridker PM; Rosenson R; ;
Circulation; 2004 Dec; 110(25):e550-3. PubMed ID: 15611380
[No Abstract] [Full Text] [Related]
3. [C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women].
Biasucci LM
Ital Heart J Suppl; 2000 Aug; 1(8):1066-7. PubMed ID: 10993018
[No Abstract] [Full Text] [Related]
4. C-reactive protein testing comes of age. Measuring low-grade inflammation can help refine cardiovascular risk.
Harv Heart Lett; 2009 Feb; 19(6):2. PubMed ID: 19575518
[No Abstract] [Full Text] [Related]
5. [C-reactive protein in cardiovascular diseases].
Lubas W; Gutkowski K
Przegl Lek; 2006; 63(7):562-6. PubMed ID: 17203810
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
Guijarro C
Circulation; 2001 Nov; 104(22):E127. PubMed ID: 11723039
[No Abstract] [Full Text] [Related]
7. C-reactive protein: "cutoff" point and clinical applicability.
Tsirpanlis G; Alevyzaki F; Triantafyllis G; Chatzipanagiotou S; Nicolaou C
Am J Kidney Dis; 2005 Aug; 46(2):368; author reply 369. PubMed ID: 16112061
[No Abstract] [Full Text] [Related]
8. [C-reactive protein: cardiovascular issues of an acute-phase protein].
Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R
Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein in cardiovascular risk prediction. Zooming in and zooming out.
Maseri A
Ital Heart J; 2001 Mar; 2(3):155-6. PubMed ID: 11305525
[No Abstract] [Full Text] [Related]
11. [Emerging risk factors for cardiovascular disease].
Demant T
Dtsch Med Wochenschr; 2004 Jan; 129(5):204-9. PubMed ID: 14735418
[No Abstract] [Full Text] [Related]
12. A better way to predict cardiovascular risk. We know how important cholesterol levels are, but what about inflammation?
Harv Womens Health Watch; 2007 Apr; 14(8):1-2. PubMed ID: 17441261
[No Abstract] [Full Text] [Related]
13. C-reactive protein and coronary heart disease.
Foody JM; Gotto AM; Wenger N
N Engl J Med; 2004 Jul; 351(3):295-8; author reply 295-8. PubMed ID: 15257565
[No Abstract] [Full Text] [Related]
14. Role of hs-CRP measurements in the current cardiovascular risk assessment.
García-Moll X; Ordóñez-Llanos J
Clin Chim Acta; 2005 May; 355(1-2):215-8. PubMed ID: 15820499
[No Abstract] [Full Text] [Related]
15. Should we measure CRP levels to assess cardiovascular risk?
Hadley RD; Graber MA
JAAPA; 2003 Jan; 16(1):17-9. PubMed ID: 12635434
[No Abstract] [Full Text] [Related]
16. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
Corson MA; Jones PH; Davidson MH
Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
[TBL] [Abstract][Full Text] [Related]
17. Does C-reactive protein predict saphenous vein graft patency?
Teoh H; Quan A; Verma S
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):277-9. PubMed ID: 17662761
[No Abstract] [Full Text] [Related]
18. [Inflammation and C-reactive protein in cardiovascular disease].
Munk PS; Larsen AI
Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
[TBL] [Abstract][Full Text] [Related]
19. Serum C-reactive protein as a marker for wellness assessment.
Kao PC; Shiesh SC; Wu TJ
Ann Clin Lab Sci; 2006; 36(2):163-9. PubMed ID: 16682512
[TBL] [Abstract][Full Text] [Related]
20. Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis.
Palmerini T; Marzocchi A; Marrozzini C; Reggiani LB; Savini C; Marinelli G; Di Bartolomeo R; Branzi A
Eur J Cardiothorac Surg; 2007 Apr; 31(4):685-90. PubMed ID: 17236785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
